Jessica Kirk is looking forward to her turn to receive the COVID-19 vaccine.
The 46-year-old mother of three and former medical secretary has a compromised immune system, which places her at greater risk of experiencing complications from the coronavirus that has already claimed more than 400,000 Americans’ lives.
Kirk is confident in the safety of the Pfizer and Moderna vaccines. Her fellow community members, however, don’t all feel the same way.
Many of Kirk’s neighbors in the predominantly Black and low-income neighborhood of East Akron are hesitant to take the vaccine because they fear negative consequences.
“They think it’s just the government giving them something just to kill off, you know… the poor Black community. … [Not] just Black people, but minorities,” Kirk said on a frigid early January afternoon outside of Dave’s Supermarket, a bustling neighborhood grocery store.
Biden pivots away from old court battles, helps ignite new ones 22 Jan 2021 / 04:42 H.
By Lawrence Hurley
WASHINGTON, Jan 21 (Reuters) - President Joe Biden in his short time in office already has turned the page on some major legal battles that consumed former President Donald Trump s administration while also taking actions certain to ignite new ones likely headed toward the U.S. Supreme Court.
The Democratic president, sworn in on Wednesday, quickly signed a flurry of executive orders that wound down some of his Republican predecessor s actions or set new priorities for his administration on issues ensnared in legal disputes such as immigration, the U.S.-Mexican border wall and LGBT rights.
E-Mail
COVID-19 has been spreading rapidly over the past several months, and the U.S. death toll has now reached 400,000. As evident from the age distribution of those fatalities, COVID-19 is dangerous not only for the elderly but for middle-aged adults, according to a Dartmouth-led study published in the For a person who is middle-aged, the risk of dying from COVID-19 is about 100 times greater than dying from an automobile accident, explains lead author Andrew Levin, a professor of economics at Dartmouth College. Generally speaking, very few children and young adults die of COVID-19. However, the risk is progressively greater for middle-aged and older adults. The odds that an infection becomes fatal is only 1:10,000 at age 25, whereas those odds are roughly 1:100 at age 60, 1:40 at age 70, and 1:10 at age 80.
dskolnick@tribtoday.com
Staff photo / Ed Runyan
Bert Pavlicko of Struthers, who served in the Navy from 1950 to 1954 during the Korean War, walks Monday from the new Veterans Affairs Outpatient Clinic at 1815 Belmont Ave. in Youngstown that will be named for Carl Nunziato. The new facility will open Wednesday. Pavlicko learned when he got there that the new facility was not yet open, and the former VA facility up the street was closed for the Martin Luther King Jr. holiday.
YOUNGSTOWN The new, larger and renamed Veterans Affairs Outpatient Clinic will open Wednesday, about a half-mile from its current location.
Share this article
Share this article
REDWOOD CITY, Calif., Jan. 19, 2021 /PRNewswire/ AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an investigator-initiated study with University Hospitals (UH) Cleveland Medical Center that will evaluate the postoperative use of DSUVIA in a prospective cohort of patients undergoing cardiac surgery with cardiopulmonary bypass following a specialized enhanced recovery protocol. Dr. Daniel Asher, cardiac anesthesiologist and Medical Director of the Mather Postanesthesia Care Unit at UH Cleveland Medical Center, will serve as the principal investigator. Key outcomes to be measured include time on mechanical ventilation following completion of the surgical procedure, both intensive care as well as hospital length of stay and total dose of opioids administered from surgery to disc